Bladder cancer: Clinical practice guidelines in oncology Review uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma
  • Urinary Bladder Neoplasms

abstract

  • Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.

publication date

  • May 27, 2013

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 23584347

Additional Document Info

start page

  • 446

end page

  • 75

volume

  • 11

number

  • 4